A 13-Year-Old Boy Has Become The First Patient Ever To Receive A Brain Implant For Epilepsy, Reducing His Daytime Seizures By 80%
A 13-year-old boy from the U.K. has become the first patient in the world to be fitted with a new brain stimulation device to control seizures. The device was surgically implanted in his skull and has already reduced his daytime seizures by 80 percent.
Oran Knowlson had the procedure done back in October 2023 as part of a trial at Great Ormond Street Hospital in London when he was 12 years old. Before the device was fitted, he would have two dozen to hundreds of seizures per day.
At the age of three, Oran developed Lennox-Gastaut syndrome, a form of epilepsy that is resistant to treatment. According to his mother, Justine, his epilepsy has “robbed him of his childhood.” She also explained the different types of seizures her son would have.
Oran would frequently fall to the ground, shake violently, and lose consciousness. At times, he would even stop breathing and require emergency medication to resuscitate him. In addition to Lennox-Gastaut syndrome, Oran has diagnoses of autism and ADHD.
Since this form of epilepsy does not respond to traditional drug treatments, scientists have been exploring alternative approaches. So far, one of the most promising options is neurostimulation, which is how the CADET Project came to be.
Oran is part of the CADET Project, a series of trials assessing the effectiveness and safety of deep brain stimulation for severe epilepsy.
The project was established as a collaborative effort between Great Ormond Street Hospital, University College London, University of Oxford, and King’s College Hospital. The brain stimulation device, called the Picostin, was made by U.K. company Amber Therapeutics.
The device works by emitting a constant electrical current that blocks or disrupts the abnormal bursts of electrical activity in the brain that characterize epileptic seizures. Oran’s surgery took eight hours to complete. The team, led by consultant pediatric neurosurgeon Martin Tisdall, inserted two electrodes into the thalamus in his brain.
The neurostimulator itself was placed in a gap in Oran’s skull, where the bone had been removed. It can be recharged through the skin with a wireless headset or handheld charger.
Monkey Business – stock.adobe.com – illustrative purposes only, not the actual people
Sign up for Chip Chick’s newsletter and get stories like this delivered to your inbox.
Oran was given a month to recover from the operation before the device was switched on. He can’t feel the stimulation, but the effect it has had on his everyday life has been extremely noticeable.
“He is more alert and with no drop seizures during the day,” Justine said. She added that his nighttime seizures were “shorter and less severe.” He has even been able to take up riding lessons while under close medical supervision.
The trial will continue with three more children with Lennox-Gastaut syndrome. In the future, the medical team plans to try to modify the neurostimulators to respond in real-time to changes in brain activity, stopping seizures before they can begin. Overall, the technology provides hope for people who have found traditional treatments ineffective.
Welcome to Billionaire Club Co LLC, your gateway to a brand-new social media experience! Sign up today and dive into over 10,000 fresh daily articles and videos curated just for your enjoyment. Enjoy the ad free experience, unlimited content interactions, and get that coveted blue check verification—all for just $1 a month!
Account Frozen
Your account is frozen. You can still view content but cannot interact with it.
Please go to your settings to update your account status.
Open Profile Settings